Merck Tbk. vs Hassana Boga Sejahtera Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Hassana Boga Sejahtera Tbk. trades at Rp57 (market cap 147.9B, 6.31M 24h volume). The key difference: Merck Tbk. is far larger — about 11.5× Hassana Boga Sejahtera Tbk.'s market cap, and Hassana Boga Sejahtera Tbk. is more actively traded (6.31M versus 37.6K). Which is the better fit depends on your goals.
| MERK | NAYZ | |
|---|---|---|
Market Cap | 1.7T | 147.9B |
Volume | 37.6K | 6.31M |
Lot | 376 | 63.09K |
Turnover | 144.47M | 360.69M |
Average Price | 3,842.23 | 57.17 |
Value | 144.47M | 360.69M |
Indicative Equilibrium Price | 3,840 | 57 |
Indicative Equilibrium Volume | 7 | 250 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Hassana Boga Sejahtera Tbk (The Company) was established based on Notarial Deed No.7 dated Oct 2, 2014 of H. Syarif Siangan Tanudjaja, S.H., notary in Jakarta. The Company started its commercial business in 2014.
Read more on NAYZ →